1cP-LSD
Chemical compound From Wikipedia, the free encyclopedia
1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. [1][2] It was first synthesized as a legal-LSD alternative by Lizard Labs, a Netherlands based research chemical laboratory.[3] In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.[4]
![]() | |
Clinical data | |
---|---|
Other names | 1cP, acid, LSD, Lucy |
Dependence liability | Low |
Addiction liability | None |
Routes of administration | By mouth, under the tongue |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Onset of action | 30 - 60 minutes |
Duration of action | 8 - 24 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C24H29N3O2 |
Molar mass | 391.515 g·mol−1 |
3D model (JSmol) | |
| |
|
Legal status

Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on 18 December 2019 and later classified it as such on 22 April 2021.[5][6]
See also
- Lysergic acid diethylamide (LSD)
- 1B-LSD
- 1DD-LSD
- 1P-LSD
- 1V-LSD
- ALD-52
- 1cP-AL-LAD
- AL-LAD
- ETH-LAD
- 1P-ETH-LAD
- PRO-LAD
- LSM-775
- LSZ
- O-Acetylpsilocin (4-AcO-DMT)
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.